Search
Rxsight Inc
RXSTAdd to Watchlist
5.610USD
+0.440+8.51%
Close 07/02, 13:00（ET）Quotes delayed by 15 min
232.23MMarket Cap
LossP/E TTM
View Detailed Chart
TradingKey 图表Intraday
1m
30m
1h
D
W
M
D
Today
+8.51%
5 Days
+9.36%
1 Month
+13.56%
6 Months
-45.95%
Year to Date
-46.16%
1 Year
-57.31%
Key Figures
5.140Open
5.670High
3.55MVolume
LossP/E TTM
LossP/E Dynamic
--Dividend TTM
8.61%Turnover Ratio
5.170Prev. Close
5.140Low
17.57MTurnover
LossP/E Static
0.84P/B
0.00%Div Yield TTM
-15.12%ROA
26.38052wk High
2.65Volume Ratio
-27.45MNet Profit
41.24MShares
-1.1357EPS TTM
1.21Beta
-17.06%ROE
5.90052wk Low
10.24%Amplitude
76.06%Gross Margin
232.23MMarket Cap
1.95Reward/Risk
4.07%Risk Rate
TradingKey Stock Score of Rxsight Inc
Currency: USD Updated: 2026-07-02Key Insights
Rxsight Inc's fundamentals are relatively healthy, and its growth potential is significant.Its valuation is considered fairly valued, ranking 83 out of 204 in the Healthcare Equipment & Supplies industry.Institutional ownership is very high.Over the past month, multiple analysts have rated it as Hold, with the highest price target at 8.93.In the medium term, the stock price is expected to trend down.The company has been performing well in the stock market over the past month, which is supported by its strong fundamentals and technicals.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.
Rxsight Inc's Score
Support & Resistance
Relevant data have not been disclosed by the company yet.
Score Analysis
Current score
Previous score
Media Coverage
Last 24 hours
Coverage Level
Very Low
Very High
Negative
Rxsight Inc Highlights
StrengthsRisks
RxSight, Inc. is a commercial-stage medical technology company dedicated to providing customized vision to patients following cataract surgery. The Company's proprietary RxSight Light Adjustable Lens system (RxSight system) is commercially available premium cataract technology that enables doctors to customize and optimize visual acuity for patients after surgery. The RxSight system consists of its RxSight Light Adjustable Lens (LAL), the RxSight Light Delivery Device (LDD), and accessories. Its LAL is an intraocular lens (IOL) made of photosensitive material that changes shape in response to specific patterns of ultraviolet (UV) light generated by its LDD. In contrast, with the RxSight system, the surgeon implants the LAL during a standard cataract procedure, determines refractive error with patient input several weeks following surgery and then uses the LDD to modify the LAL with the precise visual correction needed to achieve the patient's desired vision outcomes.
High Growth
The company's revenue has grown steadily over the past 3 years, averaging 50.97% year-on-year.
Overvalued
The company’s latest PE is -4.94, at a high 3-year percentile range.
Institutional Selling
The latest institutional holdings are 38.60M shares, decreasing 22.17% quarter-over-quarter.
Held by Bill Nygren | OAKMX
Star Investor Bill Nygren | OAKMX holds 76.79K shares of this stock.
Higher Market Activity
The company has more investor interest, with a 20-day turnover ratio of 0.55.
Analyst Rating
Based on
10
analysts
Hold
Current Rating
8.929
Target Price
+75.07%
Upside Space
Rxsight Inc News
More news coming soon, stay tuned...
Financial Indicators
EPS
Relevant data have not been disclosed by the company yet.
Total revenue
Relevant data have not been disclosed by the company yet.
Rxsight Inc Info
RxSight, Inc. is a commercial-stage medical technology company dedicated to providing customized vision to patients following cataract surgery. The Company's proprietary RxSight Light Adjustable Lens system (RxSight system) is commercially available premium cataract technology that enables doctors to customize and optimize visual acuity for patients after surgery. The RxSight system consists of its RxSight Light Adjustable Lens (LAL), the RxSight Light Delivery Device (LDD), and accessories. Its LAL is an intraocular lens (IOL) made of photosensitive material that changes shape in response to specific patterns of ultraviolet (UV) light generated by its LDD. In contrast, with the RxSight system, the surgeon implants the LAL during a standard cataract procedure, determines refractive error with patient input several weeks following surgery and then uses the LDD to modify the LAL with the precise visual correction needed to achieve the patient's desired vision outcomes.
Ticker SymbolRXST
CompanyRxsight Inc
CEOKurtz (Ron M)
Websitehttps://www.rxsight.com/
Related Instruments
-0.37%
+1.91%
+3.48%
+5.87%
+2.10%
-0.10%
+4.19%
+5.03%
+4.30%
+0.25%
+3.65%
+4.74%
+2.79%
+3.50%
+2.59%
-3.06%
+3.76%
+3.40%
+1.10%
+0.28%Popular Instruments
52800.100
-42.400 (-0.08%)
29632.600
+321.200 (+1.10%)
7498.600
+27.100 (+0.36%)
14958.000
+155.000 (+1.05%)
69503.000
+1355.000 (+1.99%)
6379.400
+26.600 (+0.42%)
68.623
+0.279 (+0.41%)
308.630
+14.250 (+4.84%)
194.830
-2.750 (-1.39%)
4174.970
+53.060 (+1.29%)
FAQs
What is the current price of Rxsight Inc (RXST)?
The current price of Rxsight Inc (RXST) is 5.61.
What is the symbol of Rxsight Inc?
The ticker symbol of Rxsight Inc is RXST.
What is the 52-week high of Rxsight Inc?
The 52-week high of Rxsight Inc is 26.38.
What is the 52-week low of Rxsight Inc?
The 52-week low of Rxsight Inc is 5.90.
What is the market capitalization of Rxsight Inc?
The market capitalization of Rxsight Inc is 231.37M.
Is Rxsight Inc (RXST) currently rated as Buy, Hold, or Sell?
According to analysts, Rxsight Inc (RXST) has an overall rating of signal_hold, with a price target of 8.93.
What is the Earnings Per Share (EPS TTM) of Rxsight Inc (RXST)?
The Earnings Per Share (EPS TTM) of Rxsight Inc (RXST) is -0.95.